lenvatinib Mesylate powder Raw Materials CAS 857890-39-2

Related Attributes

Product details

Uses and synthesis of lenvatinib Mesylate powder

lenvatinib Mesylate powder is the Mesylate of Lovatinib, a multi-target tyrosine kinase inhibitor developed by Eisai, Inc. lenvatinib Mesylate CAS 857890-39-2 has a novel binding mode. In addition to inhibiting tyrosine kinases associated with other pro-angiogenic and carcinogenic signaling pathways involved in tumor proliferation, lenvatinib Mesylate Raw Materials selectively inhibit the kinase activity of vascular endothelial growth factor (VEGF) receptors

Applications/Functions of lenvatinib Mesylate powder

• lenvatinib Mesylate powder is a multi-target tyrosine kinase inhibitor that may work against a variety of cancers, so Eisai is also investigating levatinib for other cancers
• lenvatinib Mesylate CAS 857890-39-2 is superior to sorafenib, the current standard treatment for advanced hepatocellular carcinoma.

Physicochemical Property of lenvatinib Mesylate powder

Why choose us?

HRK Factory

About Shipping